article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled.

Pharma 90
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

pharmaphorum

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. However, what is clearer still is that vulnerable groups need support and healthcare systems need to adapt to become stronger and more resistant.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FINN Partners Further Expands into Asia with Addition of SPAG

PM360

SPAG, which serves global biopharma companies, health trade associations, and health provider systems, is also one of the most awarded agencies in the region having been named Global New PR Agency in 2015, Asia-Pacific Healthcare Agency of Year (2017 & 2019) at Sabre awards, and Large Agency of the Year in 2021 & 2022 by E4M (IPRCCA).

article thumbnail

The 4 Types of Medtech Innovation  

Cesare Ferrari

Thanks to its success, two researchers, Lauterbur and Mansfield , were awarded the 2003 Nobel Prize in Medicine, and millions of patients have their lives saved or significantly improved. Magnetic Resonance Imaging (MRI) is an example of radical innovation introduced to the medical field.

article thumbnail

Top 4 Surgical Instrument Companies in the USA

Medico Reach

Its products are utilized by hospitals, dispensaries, home healthcare services, and long-term care institutions. Hospira was created on September 16, 2003, and is based in Lake Forest, Illinois.

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019. Sherene has worked in the healthcare sector for more than 20 years, including in several leadership roles at GSK. References 1. World Health Organization. The Global Health Observatory.

article thumbnail

How VMS BioMarketing Accelerated Digital Transformation with Silverline

Silver Line CRM

Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training. As a leader in this market, VMS seeks constant improvement to their patient and healthcare provider experiences.